Given the well-established effects of semaglutide in managing both diabetes and obesity, it is crucial to weigh the potential risk of NAION against the substantial therapeutic benefits of semaglutide, the researchers wrote
Schechter R, Beju D, Miller KE
Individual patient responses to medications may vary significantly, and treatment decisions should always be made in consultation with appropriate medical supervision
Does it cause hypoglycemia
Please note that if you request that your information no longer be used to provide you services, Publix or its vendors may retain your information for Publixs business purposes, such as for backups, analysis, records of deletions, legal requirements, and data retention requirements or policies
Contrasting Evidence and Key Limitations Not all analyses demonstrate a clear increased risk